Decoding the DNA of patients with advanced breast cancer has allowed scientists to identify distinct cancer "signatures" that could help predict which women are most likely to benefit from estrogen-lowering therapy, while sparing others from unnecessary treatment. Researchers at Washington University School of Medicine in St. Louis uncovered mutations linked to whether or not women respond to aromatase inhibitors, drugs often prescribed to shrink large tumors before surgery...
Fonte: healthnews.com
Indique esta NotÃcia
Compartilhar
A PHP Error was encountered
Severity: User Warning
Message: Smarty error: unable to read resource: "indiquemat_healthnews.tpl"
Filename: libs/Smarty.class.php
Line Number: 1095
